Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KARY ELDRED Insider Profile
4 Followers
KARY ELDRED, Director at Galectin Therapeutics, holds 54.64K shares in Galectin Therapeutics (Ticker: GALT). Most recently, KARY ELDRED Bought $500 shares of Galectin Therapeutics on Oct 23, 2024 for an estimated value of 1.30K.
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
+2.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that KARY ELDRED holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 26, 2023 - Jan 26, 2024
Return:+55.80%
The most profitable trade made by KARY ELDRED
KARY ELDRED's Trading History
List of latest transactions for each holding click on a transaction to see KARY ELDRED's performance on stock
You May Also Like
KARY ELDRED insider profile FAQ
What is the percentage of profitable transactions made by KARY ELDRED?
The percentage of profitable transactions made by KARY ELDRED is 50%.
What is the average return per transaction made by KARY ELDRED?
The average return per transaction made by KARY ELDRED is 2.70%.
What stocks does KARY ELDRED hold?
KARY ELDRED holds: GALT stocks.
What was KARY ELDRED’s latest transaction?
KARY ELDRED latest transaction was an Informative Buy of $1.30K.
What was KARY ELDRED's most profitable transaction?
KARY ELDRED’s most profitable transaction was an Informative Buy of GALT stock on January 26, 2023. The return on the trade was 55.80%.
What is KARY ELDRED's role in Galectin Therapeutics?
KARY ELDRED's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.